Navigation Links
Valeant Pharmaceuticals Reports 2012 Fourth Quarter Financial Results
Date:2/28/2013

MONTREAL, Feb. 28, 2013 /PRNewswire/ -- 

Fourth Quarter 2012

  • 2012 Fourth Quarter Total Revenue $986 million; an increase of 43% over the prior year
  • Organic growth (same store sales) was approximately 7%
  • Pro forma organic growth was approximately 9%
  • 2012 Fourth Quarter GAAP EPS Loss of $0.29; Cash EPS $1.22, an increase of 30% over the prior year;
  • Excluding Medicis interest expense Cash EPS $1.34, an increase of 43% over the prior year
  • 2012 Fourth Quarter GAAP Operating Cash Flow $68 million; Adjusted Operating Cash Flow $423 million 
  • Full Year 2012

  • Total 2012 revenue was $3.55 billion; an increase of 44% over the prior year
  • Organic growth (same store sales) was approximately 8%
  • Pro forma organic growth was approximately 10%
  • Total 2012 GAAP EPS Loss of $0.38; Cash EPS $4.51, an increase of 54% over the prior year
  • Total 2012 GAAP Operating Cash Flow $657 million; Adjusted Operating Cash Flow $1.3 billion
  • Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announces fourth quarter financial results for 2012.

    "We are pleased with our financial results for the fourth quarter and the full year," said J. Michael Pearson, chairman and chief executive officer. "The continued overall robust organic growth of our business, coupled with our strong cash flow generation, puts us in a solid position for another outstanding year in 2013."

    RevenueValeant's business continued to perform well in the fourth quarter of 2012 with all businesses achieving results at or above expectations. Same store organic growth was approximately 7% and pro forma organic growth was approximately 9% for the fourth quarter of 2012. (See Table 6) Total revenue was $986 million in the fourth quarter of 2012, as compared to $688 million in the fourth q
    '/>"/>

    SOURCE Valeant Pharmaceuticals International, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24

    Related medicine technology :

    1. Valeant Completes Acquisition Of Natur Produkt In Russia
    2. Valeant Pharmaceuticals To Announce 2012 Fourth Quarter Results On February 28, 2013
    3. Valeant Completes Acquisition of Medicis and Announces Date of 2013 Financial Guidance Conference Call
    4. Valeant Pharmaceuticals And Galderma Agree On Revised Agreement Terms
    5. Valeant Pharmaceuticals Announces New Management Appointments
    6. Valeant Pharmaceuticals Announces Publication of Efinaconazole Phase III Results
    7. Valeant Pharmaceuticals Annonces New $1.5 Billion Securites Repurchase Program
    8. Valeant Pharmaceuticals Receives FTC Clearance For Medicis Acquisition
    9. Valeant Pharmaceuticals Reports 2012 Third Quarter Financial Results
    10. Valeant Pharmaceuticals Reschedules Its Third Quarter 2012 Financial Results Webcast And Conference Call To November 2, 2012 Due To Hurricane Sandy
    11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... , Dec. 23, 2014 ResMed (NYSE: ... patent infringement action against Chinese medical device manufacturer BMC Medical ... ruled today that BMC,s masks listed below infringe ResMed,s patents, ... selling these masks in the United States ... N2 nasal mask , Willow nasal pillows mask ...
    (Date:12/24/2014)... 23, 2014  The American Diabetes Association is ... for people with diabetes and that all people ... of statins, in keeping with recent changes to ... American College of Cardiology (ACC) and American Heart ... most recent changes to the Association,s annual revised ...
    (Date:12/22/2014)... , Dec. 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), ... CytoSorb® blood purification technology to help fight deadly ... 28 countries worldwide, today announced the appointment of ... FACS, as its Senior Vice President of Clinical ... Dr. Di Russo is an accomplished ...
    Breaking Medicine Technology:ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
    ... Pharmaceuticals, Inc. (Nasdaq: ARNA ) announced today ... a first-in-human Phase 1 clinical trial of APD597, a ... the glucose-dependent insulinotropic receptor (GDIR) for the treatment of ... Arena and has the potential to stimulate insulin release ...
    ... Corporation of North,America today announced that the U.S. ... disodium) Injection, an intravenous,sedative-hypnotic agent for monitored anesthesia ... therapeutic procedures. , ... LUSEDRA be used only by persons,trained in the ...
    Cached Medicine Technology:Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 2Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 3Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals 4FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 2FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 3FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation 4
    (Date:12/24/2014)... 25, 2014 Recently, iFitDress.com, a famous dress ... prom dresses under $150 . All these items are brand ... website has already been updated with the new range of ... ordered so far. All iFitDress.com’s designs are made according to ... using great materials. Every outfit from the company is handpicked ...
    (Date:12/24/2014)... Dr. Vu Ho, a Dallas based facial plastic ... med-spa with the addition of new Silk Peel skin ... and services. , “Silk Peel is a procedure that ... “As a result it can address issues like acne ... or blemishes.” , Similar to microdermabrasion, Silk Peel ...
    (Date:12/24/2014)... Today, Yunx.co.uk, a hot style dress supplier that ... occasion outfits, unveils 65 new bridesmaid dresses ... prices, up to 80% off. , Yunx.co.uk’s dresses are ... designs, gorgeous looks and delicate craftsmanship. These new bridesmaid ... to designing and offering high-quality women’s dresses with fast ...
    (Date:12/24/2014)... BambooIndustry.com a famous bamboo flooring company offering bamboo ... announces its multiple layer bamboo panel board collection ... products. , Bamboo panel is the product made from ... panel board features high quality selective bamboo and eco-friendly ... bamboo panel consists of multiple layers of bamboo. , ...
    (Date:12/24/2014)... Hepatitis C infection does not contribute to mental decline in ... advances have made it possible for people with HIV to ... mood swings and other types of mental impairment as they ... infections with other viruses -- a common problem in people ... prime suspects has been the hepatitis C virus, which infects ...
    Breaking Medicine News(10 mins):Health News:Many Prom Dresses under 150 from Well-known Dress Manufacturer iFitDress.com 2Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Yunx.co.uk Unveils 65 New Bridesmaid Dresses for the UK market 2Health News:Bamboo Flooring Company Bambooindustry.com Introduces Its Multiple Layer Bamboo Panel Board Collection 2Health News:Hepatitis C Infection Isn't Related to HIV Brain Woes: Study 2
    ... The Johns Hopkins Bloomberg School of Public Health has awarded ... efforts to reduce polio globally as well as his work ... Democratic Republic of Congo. Mutombo will be presented with the ... Health in Baltimore, Md., on April 13. "Mr. Mutombo ...
    ... News) -- In most people, plaque formation in arteries occurs ... according to a new study. Researchers at the Karolinska ... surgery to remove plaque buildup in arteries in their neck. ... than the patients, who were on average 68 years old ...
    ... available in Spanish and French . ... a conflict arises within the couple. Conversely, it is men ... cause conflicts more frequently. This is the conclusion described ... prepared by professors from the Department of Social Psychology ...
    ... pregnant women, high induction and first-cesarean delivery rates do not ... published in the April issue of The Journal of ... of intervention at delivery whether high, low, or in ... new babies brings into question the skyrocketing number of both ...
    ... IL (April 13, 2011 ) This week at ... about dietary cholesterol intake and cardiovascular disease risk were ... variety of poster presentations. Experts from leading institutions discussed ... its association with heart disease risk, dispelling some commonly ...
    ... Children were the victims in more than half of the ... between 1997 and 2009, according to a new study by ... to prevent injury from the pressurized and often harsh chemical ... 0 to 4, were the most likely to be hurt ...
    Cached Medicine News:Health News:Artery Plaque Forms in Short Time Span, Scientists Say 2Health News:Women have more intense emotions than men when conflict arises within the couple 2Health News:More interventions at delivery not linked to healthier newborns 2Health News:More interventions at delivery not linked to healthier newborns 3Health News:Experts at Experimental Biology examine dietary cholesterol, egg intake and heart disease risk 2Health News:Children victims of most eye injuries from aerosols 2
    Instera pins are sterile packaged and are available in 0.89, 1.1, 1.5, and 2.0mm diameters....
    Knowles Pins are available in 9" (228mm) overall length with 9/64" (3.5mm) shaft diameter and 1/4" (6.4mm) square bead....
    Kirschner Wires are available in four point styles ranging from .028 to .062 in. Smooth tip wire available in 4, 6 and 9 in. lengths. Threaded tip available. Material: DePuy certified stainless steel...
    ... INTER FIX and INTER FIX ... designed to maximize both the ... implant. Both the INTER FIX ... Fusion devices combine the features ...
    Medicine Products: